EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

Targeted therapy of metastatic colorectal cancer (mCRC) with monoclonal antibody anti-epidermal growth factor receptor (EGFR) agents, such as cetuximab (CTX) or panitumumab, is the treatment strategy of choice in patients characterised by a wild-type (wt) RAS gene status. However, despite selection...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncol Lett
Hauptverfasser: CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2015
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4315084/
https://ncbi.nlm.nih.gov/pubmed/25663927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.2876
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge